REFERENCES
- Alayash, A. (1999). Hemoglobin-based blood substitutes: Oxygen carriers, pressor agents, or oxidants? Nature Biotechnology 17(6): 545–549, [PUBMED], [INFOTRIEVE], [CSA]
- Caron, A., Malfatti, E., Aguejouf, O., Faivre-Fiorina, B., Menu, P. (2001). Vasoconstrictive response of rat mesenteric arterioles following infusion of cross-linked, polymerized, and conjugated hemoglobin solutions. Artif. Cells Blood Substit. Immobil. Biotechnol. 29(1): 19–30, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chang, T.M.S. (1997). Blood Substitutes: Principles, Methods, Products and Clinical Trials, Basel, New York: Karger Landes Systems. (free access at www.medicine.mcgill.ca/artcell/bloodsubvol1.pdf).
- Chang, T.M.S. (2000). Red blood cell substitutes. Best Practice & Research: Clinical Haematology 13(4): 651–668, [CROSSREF], [CSA]
- Chang, T.M.S. (2003). New generations of red blood cell substitutes. J Internal Medicine 253: 527–535, [CROSSREF], [CSA]
- De Angelo, J. (1999). Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome. Exp. Opin. Pharmacother. 1: 19–29, [CROSSREF], [CSA]
- Doherty, D.H., Doyle, M.P., Curry, S.R., Vali, R.J., Fattor, T.J., Olson, J.S., Lemon, D.D. (1998). Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nature Biotechnology 16: 672–676, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Freytag, J.W., Templeton, D. (1997). OptroTM (recombinant human hemoglobin): A therapeutic for the delivery of oxygen and the restoration of blood volume in the treatment of acute blood loss in trauma and surgery, in Red Cell Substitutes; Basic Principles and Clinical Application, A.S. Rudolph, R. Rabinovici, G.Z. Feuerstein, Eds., Marcel Dekker, Inc.: New York, pp. 325–334.
- Gould, S.A., Moore, E.E., Hoyt, D.B., Burch, J.M., Haenel, J.B., Garcia, J., DeWoskin, R., Moss, G.S. (1998). The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J. Am. Coll. Surg. 187: 113–120, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gould, S.A., Moore, E.E., Hoyt, D.B., Ness, P.M., Norris, E.J., Carson, J.L., Hides, G.A., Freeman, I.H., DeWoskin, R., Moss, G.S. (2002). The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J. Am. Coll. Surg. 195(4): 445–452, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- LaMuraglia, G.M., O'Hara, P.J., Baker, W.H., Naslund, T.C., Norris, E.J., Li, J., Vandermeersch, E. (2000). The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J. Vasc. Surg. 31: 299–308, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sprung, J., Kindscher, J.D., Wahr, J.A., Levy, J.H., Monk, T.G., Moritz, M.W., O'Hara, P.J. (2002). The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: Results of a multicenter, randomized, single-blinded trial. Anesth Analg 94: 799–808, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lieberthal, W., Fuhro, R., Alam, H., Rhee, P., Szebeni, J., Hechtman, H.B., Favuzza, J., Veech, R.L., Valeri, C.R. (2002). Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions. Shock 17(1): 61–69, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Matheson, B., Kwansa, H.E., Bucci, E., Rebel, A., Koehler, R.C. (2002). Vascular response to infusions of a nonextravasating hemoglobin polymer. J. Appl. Physiol. 93: 1479–1486, [PUBMED], [INFOTRIEVE], [CSA]
- Vuylsteke, A., Davidson, H.J., Ho, W.S., Ritchie, A.J., Callingham, B.A., White, R., Hiley, C.R. (2001). Effect of the blood substitute diaspirin crosslinked hemoglobin in rat mesenteric and human radial collateral arteries. J. Cardiovasc. Pharmacol. 37(4): 394–405, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Winslow, R. (2003). Current status of blood substitute research: Towards a new paradigm. J. Int. Med. 253: 508–517, [CROSSREF], [CSA]
- Chang, T.M.S. Personal communication.